tiprankstipranks
Trending News
More News >
Medical Net,Inc. (JP:3645)
:3645
Japanese Market

Medical Net,Inc. (3645) Ratios

Compare
0 Followers

Medical Net,Inc. Ratios

JP:3645's free cash flow for Q2 2024 was ¥0.34. For the 2024 fiscal year, JP:3645's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
1.71 1.71 1.60 2.08 1.78
Quick Ratio
1.62 1.62 1.50 2.04 1.74
Cash Ratio
1.06 1.06 0.87 1.20 0.89
Solvency Ratio
0.12 0.12 0.29 0.18 0.14
Operating Cash Flow Ratio
0.30 0.30 0.26 0.54 0.12
Short-Term Operating Cash Flow Coverage
0.61 0.61 0.52 1.51 0.22
Net Current Asset Value
¥ 475.28M¥ 921.23M¥ 661.08M¥ 658.21M¥ 475.28M
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.23 0.25 0.18 0.24
Debt-to-Equity Ratio
0.41 0.41 0.45 0.31 0.41
Debt-to-Capital Ratio
0.29 0.29 0.31 0.24 0.29
Long-Term Debt-to-Capital Ratio
0.04 0.04 0.06 0.09 0.05
Financial Leverage Ratio
1.81 1.81 1.85 1.70 1.74
Debt Service Coverage Ratio
0.24 0.24 0.65 0.63 0.29
Interest Coverage Ratio
125.46 125.46 225.49 174.72 49.29
Debt to Market Cap
0.22 0.22 0.19 0.07 0.20
Interest Debt Per Share
88.59 88.59 88.62 45.63 48.21
Net Debt to EBITDA
-1.53 -2.30 -0.63 -1.73 -1.53
Profitability Margins
Gross Profit Margin
39.57%39.57%38.98%40.56%33.33%
EBIT Margin
5.64%5.64%14.30%8.81%3.64%
EBITDA Margin
7.02%7.02%15.24%9.67%4.35%
Operating Profit Margin
8.44%8.44%11.88%11.40%3.65%
Pretax Profit Margin
5.57%5.57%14.25%8.75%3.56%
Net Profit Margin
2.58%2.58%10.15%4.46%2.72%
Continuous Operations Profit Margin
2.42%2.42%10.57%4.74%2.86%
Net Income Per EBT
46.33%46.33%71.21%51.03%76.31%
EBT Per EBIT
66.05%66.05%119.92%76.70%97.74%
Return on Assets (ROA)
4.57%3.35%12.07%6.15%4.57%
Return on Equity (ROE)
7.96%6.06%22.32%10.43%7.96%
Return on Capital Employed (ROCE)
10.04%18.71%24.07%23.92%10.04%
Return on Invested Capital (ROIC)
6.01%6.02%13.15%10.92%6.01%
Return on Tangible Assets
5.06%3.67%14.20%6.81%5.06%
Earnings Yield
3.81%3.30%9.32%2.38%3.81%
Efficiency Ratios
Receivables Turnover
6.67 6.67 0.00 6.54 6.99
Payables Turnover
8.42 8.42 8.80 15.55 18.55
Inventory Turnover
21.94 21.94 17.67 58.55 68.43
Fixed Asset Turnover
40.39 40.39 35.26 73.67 76.47
Asset Turnover
1.30 1.30 1.19 1.38 1.68
Working Capital Turnover Ratio
5.00 5.00 4.80 4.43 0.00
Cash Conversion Cycle
37.87 28.00 -20.84 38.53 37.87
Days of Sales Outstanding
52.22 54.70 0.00 55.77 52.22
Days of Inventory Outstanding
5.33 16.64 20.65 6.23 5.33
Days of Payables Outstanding
19.68 43.34 41.49 23.47 19.68
Operating Cycle
57.55 71.34 20.65 62.00 57.55
Cash Flow Ratios
Operating Cash Flow Per Share
47.89 47.89 39.15 46.42 9.13
Free Cash Flow Per Share
45.59 45.59 38.90 44.87 8.11
CapEx Per Share
2.30 2.30 0.25 1.54 1.02
Free Cash Flow to Operating Cash Flow
0.95 0.95 0.99 0.97 0.89
Dividend Paid and CapEx Coverage Ratio
7.69 7.69 9.41 20.43 4.00
Capital Expenditure Coverage Ratio
20.80 20.80 158.22 30.09 8.96
Operating Cash Flow Coverage Ratio
0.54 0.54 0.44 1.02 0.19
Operating Cash Flow to Sales Ratio
0.10 0.10 0.09 0.13 0.03
Free Cash Flow Yield
3.34%11.60%8.35%6.96%3.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
30.31 30.31 10.73 41.99 26.26
Price-to-Sales (P/S) Ratio
0.78 0.78 1.09 1.87 0.71
Price-to-Book (P/B) Ratio
1.84 1.84 2.39 4.38 2.09
Price-to-Free Cash Flow (P/FCF) Ratio
8.62 8.62 11.98 14.37 29.95
Price-to-Operating Cash Flow Ratio
8.21 8.21 11.90 13.90 26.61
Price-to-Earnings Growth (PEG) Ratio
-0.43 -0.43 0.06 0.64 0.00
Price-to-Fair Value
1.84 1.84 2.39 4.38 2.09
Enterprise Value Multiple
8.85 8.85 6.51 17.66 14.90
Enterprise Value
1.89B 2.79B 3.72B 4.96B 1.89B
EV to EBITDA
14.90 8.85 6.51 17.66 14.90
EV to Sales
0.65 0.62 0.99 1.71 0.65
EV to Free Cash Flow
27.16 6.84 10.92 13.09 27.16
EV to Operating Cash Flow
24.13 6.51 10.85 12.66 24.13
Tangible Book Value Per Share
181.13 181.13 143.98 125.09 97.84
Shareholders’ Equity Per Share
213.93 213.93 194.63 147.22 116.23
Tax and Other Ratios
Effective Tax Rate
0.57 0.57 0.26 0.46 0.20
Revenue Per Share
502.28 502.28 428.05 344.05 340.33
Net Income Per Share
12.97 12.97 43.44 15.36 9.25
Tax Burden
0.76 0.46 0.71 0.51 0.76
Interest Burden
0.98 0.99 1.00 0.99 0.98
Research & Development to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.04 0.03 0.04 0.04 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.75 1.71 0.64 1.54 0.75
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis